NetworkNewsBreaks – Axcella Health Inc. (NASDAQ: AXLA) Secures $60.1M in Underwritten Public Offering
Axcella Health (NASDAQ: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (“EMMs”) to pioneer a new approach for treating complex diseases and improving health, has closed an underwritten public offering of 12,650,000 shares of its common stock, including 1,650,000 additional shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, Axcella secured approximately $60.1 million in gross proceeds, with each of the shares sold at the public offering price of $4.75. Axcella intends to use the proceeds, together with its existing cash and cash equivalents, to advance its current programs…







